Review





Similar Products

90
ImmunoWay Biotechnology Company ampka1/2 polyclonal antibody yt0216
Ampka1/2 Polyclonal Antibody Yt0216, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka1/2 polyclonal antibody yt0216/product/ImmunoWay Biotechnology Company
Average 90 stars, based on 1 article reviews
ampka1/2 polyclonal antibody yt0216 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc ampka1
Ampka1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka1/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
ampka1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Addgene inc pet28 mbp naaef ampka1 13 476 529 550 b2 76 272 g1 24 327
Pet28 Mbp Naaef Ampka1 13 476 529 550 B2 76 272 G1 24 327, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pet28 mbp naaef ampka1 13 476 529 550 b2 76 272 g1 24 327/product/Addgene inc
Average 94 stars, based on 1 article reviews
pet28 mbp naaef ampka1 13 476 529 550 b2 76 272 g1 24 327 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
ABclonal Biotechnology anti-ampka1/ampka2
Anti Ampka1/Ampka2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-ampka1/ampka2/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
anti-ampka1/ampka2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Inserm Transfert ampka1 / mice
Ampka1 / Mice, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka1 / mice/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
ampka1 / mice - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology anti-phospho-ampka1/ampka2-t183/t172
Anti Phospho Ampka1/Ampka2 T183/T172, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-phospho-ampka1/ampka2-t183/t172/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
anti-phospho-ampka1/ampka2-t183/t172 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Ribobio co small interfering rnas (sirnas) targeting mcur1, tsc1, tsc2, ampka1, camkk2, pu.1 and a non-targeting control sirna
MCUR1 downregulation reduces activation of the mTOR pathway through the Ca 2+ -CAMMK2-AMPK axis in human cord blood CD34 + HSPCs (A) The effects of MCUR1 knockdown on mitochondrial ([Ca 2+ ] m ; red) and cytoplasmic ([Ca 2+ ] c ; green) Ca 2+ responses in human cord blood CD34 + HSPCs before and after ionomycin exposure (2.5 μM), under hypoxia (1% O 2 ) and EPO treatment (3 U/mL) for 7 days. (B) Knockdown of <t>AMPKa1</t> induces mTOR activity and abolishes the decreased mTOR activity by MCUR1 knockdown. (C) The effect of AMPKa1 knockdown on the changes in percentages of basophilic (Bas), polychromatophilic (Pol), and orthochromatic (Ort) cells and erythroblasts and erythrocytes (Ery) by MCUR1 knockdown. Left side shows the representative images. (D) The effect of AMPKa1 knockdown on the decreased fraction of erythroblasts by MCUR1 knockdown. (E) The effect of AMPKa1 knockdown on the decreased fraction of CFU-E population by MCUR1 knockdown. (F) The effects of MCUR1 knockdown on the activity of two upstream kinases of AMPKα, LKB1 and CAMKK2. (G) The effects of inhibition of CAMMK2 activity (by BAPTA-AM, an intracellular Ca 2+ chelator; 1 μM) on the increased AMPKα activity and decreased mTOR activity by MCUR1 knockdown. Data are shown as mean ± SD. Data analyses were conducted by two-tailed t test except where noted otherwise. n.s., not significant. ∗∗ p < 0.01 and ∗∗∗ p < 0.001.
Small Interfering Rnas (Sirnas) Targeting Mcur1, Tsc1, Tsc2, Ampka1, Camkk2, Pu.1 And A Non Targeting Control Sirna, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small interfering rnas (sirnas) targeting mcur1, tsc1, tsc2, ampka1, camkk2, pu.1 and a non-targeting control sirna/product/Ribobio co
Average 90 stars, based on 1 article reviews
small interfering rnas (sirnas) targeting mcur1, tsc1, tsc2, ampka1, camkk2, pu.1 and a non-targeting control sirna - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology ampka1/a2 rabbit pab (ampk) antibody
MCUR1 downregulation reduces activation of the mTOR pathway through the Ca 2+ -CAMMK2-AMPK axis in human cord blood CD34 + HSPCs (A) The effects of MCUR1 knockdown on mitochondrial ([Ca 2+ ] m ; red) and cytoplasmic ([Ca 2+ ] c ; green) Ca 2+ responses in human cord blood CD34 + HSPCs before and after ionomycin exposure (2.5 μM), under hypoxia (1% O 2 ) and EPO treatment (3 U/mL) for 7 days. (B) Knockdown of <t>AMPKa1</t> induces mTOR activity and abolishes the decreased mTOR activity by MCUR1 knockdown. (C) The effect of AMPKa1 knockdown on the changes in percentages of basophilic (Bas), polychromatophilic (Pol), and orthochromatic (Ort) cells and erythroblasts and erythrocytes (Ery) by MCUR1 knockdown. Left side shows the representative images. (D) The effect of AMPKa1 knockdown on the decreased fraction of erythroblasts by MCUR1 knockdown. (E) The effect of AMPKa1 knockdown on the decreased fraction of CFU-E population by MCUR1 knockdown. (F) The effects of MCUR1 knockdown on the activity of two upstream kinases of AMPKα, LKB1 and CAMKK2. (G) The effects of inhibition of CAMMK2 activity (by BAPTA-AM, an intracellular Ca 2+ chelator; 1 μM) on the increased AMPKα activity and decreased mTOR activity by MCUR1 knockdown. Data are shown as mean ± SD. Data analyses were conducted by two-tailed t test except where noted otherwise. n.s., not significant. ∗∗ p < 0.01 and ∗∗∗ p < 0.001.
Ampka1/A2 Rabbit Pab (Ampk) Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka1/a2 rabbit pab (ampk) antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
ampka1/a2 rabbit pab (ampk) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology ampka1/a2 sirna #45312
MCUR1 downregulation reduces activation of the mTOR pathway through the Ca 2+ -CAMMK2-AMPK axis in human cord blood CD34 + HSPCs (A) The effects of MCUR1 knockdown on mitochondrial ([Ca 2+ ] m ; red) and cytoplasmic ([Ca 2+ ] c ; green) Ca 2+ responses in human cord blood CD34 + HSPCs before and after ionomycin exposure (2.5 μM), under hypoxia (1% O 2 ) and EPO treatment (3 U/mL) for 7 days. (B) Knockdown of <t>AMPKa1</t> induces mTOR activity and abolishes the decreased mTOR activity by MCUR1 knockdown. (C) The effect of AMPKa1 knockdown on the changes in percentages of basophilic (Bas), polychromatophilic (Pol), and orthochromatic (Ort) cells and erythroblasts and erythrocytes (Ery) by MCUR1 knockdown. Left side shows the representative images. (D) The effect of AMPKa1 knockdown on the decreased fraction of erythroblasts by MCUR1 knockdown. (E) The effect of AMPKa1 knockdown on the decreased fraction of CFU-E population by MCUR1 knockdown. (F) The effects of MCUR1 knockdown on the activity of two upstream kinases of AMPKα, LKB1 and CAMKK2. (G) The effects of inhibition of CAMMK2 activity (by BAPTA-AM, an intracellular Ca 2+ chelator; 1 μM) on the increased AMPKα activity and decreased mTOR activity by MCUR1 knockdown. Data are shown as mean ± SD. Data analyses were conducted by two-tailed t test except where noted otherwise. n.s., not significant. ∗∗ p < 0.01 and ∗∗∗ p < 0.001.
Ampka1/A2 Sirna #45312, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampka1/a2 sirna #45312/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
ampka1/a2 sirna #45312 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory mouse c57bl/6- ampka1 flox/flox prkaa1 tm1.1sjm /j
MCUR1 downregulation reduces activation of the mTOR pathway through the Ca 2+ -CAMMK2-AMPK axis in human cord blood CD34 + HSPCs (A) The effects of MCUR1 knockdown on mitochondrial ([Ca 2+ ] m ; red) and cytoplasmic ([Ca 2+ ] c ; green) Ca 2+ responses in human cord blood CD34 + HSPCs before and after ionomycin exposure (2.5 μM), under hypoxia (1% O 2 ) and EPO treatment (3 U/mL) for 7 days. (B) Knockdown of <t>AMPKa1</t> induces mTOR activity and abolishes the decreased mTOR activity by MCUR1 knockdown. (C) The effect of AMPKa1 knockdown on the changes in percentages of basophilic (Bas), polychromatophilic (Pol), and orthochromatic (Ort) cells and erythroblasts and erythrocytes (Ery) by MCUR1 knockdown. Left side shows the representative images. (D) The effect of AMPKa1 knockdown on the decreased fraction of erythroblasts by MCUR1 knockdown. (E) The effect of AMPKa1 knockdown on the decreased fraction of CFU-E population by MCUR1 knockdown. (F) The effects of MCUR1 knockdown on the activity of two upstream kinases of AMPKα, LKB1 and CAMKK2. (G) The effects of inhibition of CAMMK2 activity (by BAPTA-AM, an intracellular Ca 2+ chelator; 1 μM) on the increased AMPKα activity and decreased mTOR activity by MCUR1 knockdown. Data are shown as mean ± SD. Data analyses were conducted by two-tailed t test except where noted otherwise. n.s., not significant. ∗∗ p < 0.01 and ∗∗∗ p < 0.001.
Mouse C57bl/6 Ampka1 Flox/Flox Prkaa1 Tm1.1sjm /J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse c57bl/6- ampka1 flox/flox prkaa1 tm1.1sjm /j/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
mouse c57bl/6- ampka1 flox/flox prkaa1 tm1.1sjm /j - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


MCUR1 downregulation reduces activation of the mTOR pathway through the Ca 2+ -CAMMK2-AMPK axis in human cord blood CD34 + HSPCs (A) The effects of MCUR1 knockdown on mitochondrial ([Ca 2+ ] m ; red) and cytoplasmic ([Ca 2+ ] c ; green) Ca 2+ responses in human cord blood CD34 + HSPCs before and after ionomycin exposure (2.5 μM), under hypoxia (1% O 2 ) and EPO treatment (3 U/mL) for 7 days. (B) Knockdown of AMPKa1 induces mTOR activity and abolishes the decreased mTOR activity by MCUR1 knockdown. (C) The effect of AMPKa1 knockdown on the changes in percentages of basophilic (Bas), polychromatophilic (Pol), and orthochromatic (Ort) cells and erythroblasts and erythrocytes (Ery) by MCUR1 knockdown. Left side shows the representative images. (D) The effect of AMPKa1 knockdown on the decreased fraction of erythroblasts by MCUR1 knockdown. (E) The effect of AMPKa1 knockdown on the decreased fraction of CFU-E population by MCUR1 knockdown. (F) The effects of MCUR1 knockdown on the activity of two upstream kinases of AMPKα, LKB1 and CAMKK2. (G) The effects of inhibition of CAMMK2 activity (by BAPTA-AM, an intracellular Ca 2+ chelator; 1 μM) on the increased AMPKα activity and decreased mTOR activity by MCUR1 knockdown. Data are shown as mean ± SD. Data analyses were conducted by two-tailed t test except where noted otherwise. n.s., not significant. ∗∗ p < 0.01 and ∗∗∗ p < 0.001.

Journal: Cell Genomics

Article Title: A highland-adaptation variant near MCUR1 reduces its transcription and attenuates erythrogenesis in Tibetans

doi: 10.1016/j.xgen.2025.100782

Figure Lengend Snippet: MCUR1 downregulation reduces activation of the mTOR pathway through the Ca 2+ -CAMMK2-AMPK axis in human cord blood CD34 + HSPCs (A) The effects of MCUR1 knockdown on mitochondrial ([Ca 2+ ] m ; red) and cytoplasmic ([Ca 2+ ] c ; green) Ca 2+ responses in human cord blood CD34 + HSPCs before and after ionomycin exposure (2.5 μM), under hypoxia (1% O 2 ) and EPO treatment (3 U/mL) for 7 days. (B) Knockdown of AMPKa1 induces mTOR activity and abolishes the decreased mTOR activity by MCUR1 knockdown. (C) The effect of AMPKa1 knockdown on the changes in percentages of basophilic (Bas), polychromatophilic (Pol), and orthochromatic (Ort) cells and erythroblasts and erythrocytes (Ery) by MCUR1 knockdown. Left side shows the representative images. (D) The effect of AMPKa1 knockdown on the decreased fraction of erythroblasts by MCUR1 knockdown. (E) The effect of AMPKa1 knockdown on the decreased fraction of CFU-E population by MCUR1 knockdown. (F) The effects of MCUR1 knockdown on the activity of two upstream kinases of AMPKα, LKB1 and CAMKK2. (G) The effects of inhibition of CAMMK2 activity (by BAPTA-AM, an intracellular Ca 2+ chelator; 1 μM) on the increased AMPKα activity and decreased mTOR activity by MCUR1 knockdown. Data are shown as mean ± SD. Data analyses were conducted by two-tailed t test except where noted otherwise. n.s., not significant. ∗∗ p < 0.01 and ∗∗∗ p < 0.001.

Article Snippet: The small interfering RNAs (siRNAs) targeting MCUR1 , TSC1 , TSC2 , AMPKa1 , CAMKK2 , PU.1 and a non-targeting control siRNA were synthesized by RiboBio (Guangzhou City, China).

Techniques: Activation Assay, Knockdown, Activity Assay, Inhibition, Two Tailed Test